{"id":"https://openalex.org/W2080194097","doi":"https://doi.org/10.4088/jcp.09m05031yel","title":"Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder","display_name":"Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder","publication_year":2010,"publication_date":"2010-06-15","ids":{"openalex":"https://openalex.org/W2080194097","doi":"https://doi.org/10.4088/jcp.09m05031yel","mag":"2080194097","pmid":"https://pubmed.ncbi.nlm.nih.gov/20584515"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.09m05031yel","doi":"https://doi.org/10.4088/jcp.09m05031yel","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.09m05031yel","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113536965","display_name":"Michael S. Ritsner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]}],"countries":["IL"],"is_corresponding":true,"raw_author_name":"Michael S. Ritsner","raw_affiliation_strings":["Department of Psychiatry, The Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology, Haifa, Israel. ritsner@sm.health.gov.il"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, The Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology, Haifa, Israel. ritsner@sm.health.gov.il","institution_ids":["https://openalex.org/I174306211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028436352","display_name":"Anatoly Gibel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anatoly Gibel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013392825","display_name":"Tatyana Shleifer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tatyana Shleifer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110156467","display_name":"Igor Boguslavsky","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Igor Boguslavsky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103907675","display_name":"Ahmad Zayed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmad Zayed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066501994","display_name":"Rachel Maayan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Maayan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063898483","display_name":"Abraham Weizman","orcid":"https://orcid.org/0000-0002-9765-8938","observed_orcids":["https://orcid.org/0000-0002-9765-8938"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abraham Weizman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5059532230","display_name":"Vladimir Lerner","orcid":"https://orcid.org/0000-0002-2643-7302","observed_orcids":["https://orcid.org/0000-0002-2643-7302"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vladimir Lerner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5113536965"],"corresponding_institution_ids":["https://openalex.org/I174306211"],"apc_list":null,"apc_paid":null,"fwci":4.7964,"has_fulltext":false,"cited_by_count":88,"citation_normalized_percentile":{"value":0.95129655,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"71","issue":"10","first_page":"1351","last_page":"1362"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pregnenolone","display_name":"pregnenolone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dehydroepiandrosterone","display_name":"dehydroepiandrosterone","score":1.0},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.7350000143051147},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9129999876022339},{"id":"https://openalex.org/keywords/schizoaffective-disorder","display_name":"schizoaffective disorder","score":1.0},{"id":"https://openalex.org/keywords/antipsychotic-augmentation","display_name":"antipsychotic augmentation","score":0.8410000205039978},{"id":"https://openalex.org/keywords/positive-symptoms","display_name":"positive symptoms","score":0.8899999856948853},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9940000176429749},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.9850000143051147},{"id":"https://openalex.org/keywords/attention","display_name":"attention","score":0.6100000143051147},{"id":"https://openalex.org/keywords/working-memory","display_name":"working memory","score":0.9980000257492065},{"id":"https://openalex.org/keywords/neurocognitive-function","display_name":"neurocognitive function","score":0.7269999980926514},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C2780325297","wikidata":"https://www.wikidata.org/wiki/Q834047","display_name":"Schizoaffective disorder","level":3,"score":0.6736142635345459},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6250597834587097},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5966337323188782},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.5847455263137817},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5144303441047668},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.5047742128372192},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.46632033586502075},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.4653172492980957},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.46371960639953613},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4515593647956848},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.43726563453674316},{"id":"https://openalex.org/C123273963","wikidata":"https://www.wikidata.org/wiki/Q624758","display_name":"Psychopathology","level":2,"score":0.4318878948688507},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.39566242694854736},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.3416842222213745},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33141911029815674},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.12431761622428894},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001288","descriptor_name":"Attention","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003687","descriptor_name":"Dehydroepiandrosterone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003687","descriptor_name":"Dehydroepiandrosterone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008570","descriptor_name":"Memory, Short-Term","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011284","descriptor_name":"Pregnenolone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011284","descriptor_name":"Pregnenolone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018377","descriptor_name":"Neurotransmitter Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018377","descriptor_name":"Neurotransmitter Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.09m05031yel","doi":"https://doi.org/10.4088/jcp.09m05031yel","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.09m05031yel","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:20584515","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20584515","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2068341809","https://openalex.org/W2019378549","https://openalex.org/W1593774567","https://openalex.org/W2036594341","https://openalex.org/W2172108890","https://openalex.org/W2032359153","https://openalex.org/W2133447633","https://openalex.org/W1271082088","https://openalex.org/W2729534900","https://openalex.org/W44771556"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Pregnenolone":[1],"(PREG)":[2],"and":[3,18,28,37,42,83,113,117,130,133,149,170,175,179,203,210,238,251,266,268,272,278],"dehydroepiandrosterone":[4],"(DHEA)":[5],"are":[6,23,138,286],"reported":[7],"to":[8,20,48,288],"have":[9],"a":[10],"modulatory":[11],"effect":[12],"on":[13,39,191],"neuronal":[14],"excitability,":[15],"synaptic":[16],"plasticity,":[17],"response":[19],"stress;":[21],"they":[22],"associated":[24],"with":[25,54,155,186,220,229],"mood":[26],"regulation":[27],"cognitive":[29,43],"performance.":[30],"We":[31],"investigated":[32],"the":[33,123,131,196,290],"influence":[34],"of":[35,52,71,76,81,89,127,147,206,216,249,263,276,293],"PREG":[36,72,77,250,258],"DHEA":[38,230,252],"psychotic":[40],"symptoms":[41,237,265],"functioning":[44,205],"as":[45,85,119],"an":[46,86],"add-on":[47],"ongoing":[49],"antipsychotic":[50],"treatment":[51,88,148],"patients":[53,96,142,207,233],"chronic":[55,91],"schizophrenia":[56,92,277],"or":[57,93],"schizoaffective":[58,94,279],"disorder.":[59],"METHOD:":[60],"This":[61],"8-week,":[62],"double-blind,":[63],"randomized,":[64],"placebo-controlled,":[65],"2-center":[66],"study":[67,197],"compared":[68],"30":[69],"mg/d":[70,75,80],"(PREG-30),":[73],"200":[74],"(PREG-200),":[78],"400":[79],"DHEA,":[82,221],"placebo":[84,209],"adjunctive":[87],"58":[90],"disorder":[95,280],"(DSM-IV).":[97],"The":[98,108,199,247],"data":[99],"were":[100,111,240],"collected":[101],"from":[102],"February":[103],"2005":[104],"until":[105],"June":[106],"2007.":[107],"outcome":[109,192],"measures":[110],"symptomatic":[112],"neurocognitive":[114],"changes,":[115],"functioning,":[116],"tolerability":[118],"assessed":[120],"primarily":[121],"by":[122,244],"Clinical":[124],"Global":[125],"Impressions-Severity":[126],"Illness":[128],"scale":[129],"Positive":[132],"Negative":[134,236],"Syndrome":[135],"Scale.":[136],"Analyses":[137],"presented":[139],"for":[140,150,195],"44":[141],"who":[143,157],"completed":[144],"8":[145],"weeks":[146],"14":[151],"noncompleters.":[152],"RESULTS:":[153],"Compared":[154],"subjects":[156,184,218,227],"received":[158],"placebo,":[159],"those":[160,217],"administered":[161],"PREG-30":[162,211],"had":[163],"significant":[164,261],"reductions":[165],"in":[166,177,226,232,270],"positive":[167,264],"symptom":[168],"scores":[169,194],"extrapyramidal":[171],"side":[172],"effects":[173],"(EPS)":[174],"improvement":[176,269],"attention":[178,271],"working":[180,273],"memory":[181,274],"performance,":[182],"whereas":[183],"treated":[185,219,228],"PREG-200":[187],"did":[188],"not":[189,241],"differ":[190],"variable":[193],"period.":[198],"general":[200,204],"psychopathology":[201],"severity":[202],"receiving":[208,234],"improved":[212,224],"more":[213,225],"than":[214,231],"that":[215],"while":[222],"EPS":[223,267],"placebo.":[235],"akathisia":[239],"significantly":[242],"benefited":[243],"any":[245],"treatment.":[246],"administration":[248],"was":[253],"well":[254],"tolerated.":[255],"CONCLUSIONS:":[256],"Low-dose":[257],"augmentation":[259],"demonstrated":[260],"amelioration":[262],"performance":[275],"patients.":[281],"Further":[282],"double-blind":[283],"controlled":[284],"studies":[285],"needed":[287],"investigate":[289],"clinical":[291],"benefit":[292],"pregnenolone":[294],"augmentation.":[295],"TRIAL":[296],"REGISTRATION:":[297],"clinicaltrials.gov":[298],"Identifier:":[299],"NCT00174889.":[300]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}